pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

STAT Health Tech newsletter previews EPIC probe, Teladoc surprise and AI payment challenges

Oct 29, 2026·read at STAT ↗Neutral

The latest STAT Health Tech newsletter, authored by correspondent Mario Aguilar, highlights several emerging topics in health technology. It flags an upcoming investigation into EPIC, the electronic health record giant, suggesting deeper scrutiny of its practices.

A surprise involving telehealth provider Teladoc is also teased, though details are not disclosed in the brief preview.

The edition raises the question of how Medicare and other payers will fund artificial-intelligence tools in clinical care, signaling ongoing policy debates.

Finally, STAT announces it will host a session on the main stage at the HLTH conference in Las Vegas on Nov. 18, underscoring its role in shaping health-tech discourse.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: The EPIC investigation, and a Teladoc surprise”

read at STAT ↗
448 words · retrieved 21m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoSTAT+: New federal rule will require prescription drug middlemen to share secret payments dataSTAT
  • 3h agoSTAT+: Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHASTAT
  • 3h agoSTAT+: El-Sayed claps back at RFK Jr., and FDA’s ‘enforcement discretion’ on peptidesSTAT
  • 4h agoSTAT+: HHS green lights six peptides, despite concerns from FDA scientistsSTAT
  • 4h agoMartin Kulldorff critiques scientific gatekeepers at NIH lectureSTAT